Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,165 GBX | -0.21% | +1.10% | +14.72% |
11:35am | AstraZeneca: CHMP recommends approval of Tagrisso in the EU | CF |
11:19am | AstraZeneca's Tagrisso Reduces Lung Cancer Progression in Phase 3 Trial | MT |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Transcripts